ABEONA THERAPEUTICS INC.: income tax expense or benefit
Income tax expense or benefit for ABEONA THERAPEUTICS INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All ABEONA THERAPEUTICS INC. financial histories
What this measure means
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
Exact concept: us-gaap:IncomeTaxExpenseBenefit. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-01-01 to 2025-12-31. The SEC response was captured on 2026-09-19.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 100,000 | USD | 2026-03-17 | 10-K · 0001493152-26-010413 |
| 2018-01-01 | 2018-12-31 | 0 | USD | 2019-03-18 | 10-K · 0001144204-19-014623 |
| 2017-01-01 | 2017-12-31 | 0 | USD | 2019-03-18 | 10-K · 0001144204-19-014623 |
| 2016-01-01 | 2016-12-31 | 0 | USD | 2019-03-18 | 10-K · 0001144204-19-014623 |
| 2015-01-01 | 2015-12-31 | 0 | USD | 2017-03-30 | 10-K · 0001144204-17-017709 |
| 2014-01-01 | 2014-12-31 | 0 | USD | 2016-03-30 | 10-K · 0001144204-16-091600 |
| 2013-01-01 | 2013-12-31 | 0 | USD | 2015-03-31 | 10-K · 0001144204-15-020126 |
| 2012-01-01 | 2012-12-31 | 0 | USD | 2014-03-26 | 10-K · 0000318306-14-000006 |
| 2011-01-01 | 2011-12-31 | 17,000 | USD | 2013-03-20 | 10-K · 0000318306-13-000004 |
| 2010-01-01 | 2010-12-31 | 0 | USD | 2012-03-23 | 10-K · 0000318306-12-000020 |
Related financial histories
- ABEONA THERAPEUTICS INC.: total assets
- ABEONA THERAPEUTICS INC.: total liabilities
- ABEONA THERAPEUTICS INC.: stockholders equity
- ABEONA THERAPEUTICS INC.: cash and cash equivalents
- ABEONA THERAPEUTICS INC.: net income or loss
- ABEONA THERAPEUTICS INC.: operating cash flow
- ABEONA THERAPEUTICS INC.: capital expenditure payments
- ABEONA THERAPEUTICS INC.: revenue
- ABEONA THERAPEUTICS INC.: contract revenue excluding tax
- ABEONA THERAPEUTICS INC.: financing cash flow
- ABEONA THERAPEUTICS INC.: investing cash flow
- ABEONA THERAPEUTICS INC.: retained earnings or deficit
- ABEONA THERAPEUTICS INC.: basic weighted-average shares
- ABEONA THERAPEUTICS INC.: diluted weighted-average shares
- ABEONA THERAPEUTICS INC.: basic earnings per share
- ABEONA THERAPEUTICS INC.: diluted earnings per share
- ABEONA THERAPEUTICS INC.: net property, plant and equipment
- ABEONA THERAPEUTICS INC.: share-based compensation expense
- ABEONA THERAPEUTICS INC.: operating income or loss
- ABEONA THERAPEUTICS INC.: current assets
- ABEONA THERAPEUTICS INC.: interest expense
- ABEONA THERAPEUTICS INC.: current liabilities
- ABEONA THERAPEUTICS INC.: current accounts payable
- ABEONA THERAPEUTICS INC.: goodwill carrying amount
- ABEONA THERAPEUTICS INC.: net finite-lived intangible assets
- ABEONA THERAPEUTICS INC.: operating expenses
- ABEONA THERAPEUTICS INC.: net inventory
- ABEONA THERAPEUTICS INC.: selling, general and administrative expense
- ABEONA THERAPEUTICS INC.: research and development expense
Inspect the source
- Entity
- ABEONA THERAPEUTICS INC. / CIK 0000318306
- Captured
- 2026-09-19T14:56:42.310Z
- SEC response SHA-256
636768f46653d2a6ef88c7a2f3600aa36414b265029032bf07e61c32ce5542a2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000318306.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))